EyeNet Magazine



   
 
Products & Services
 
 

• Updated Accommodating IOL
• Flashing Fixation Sticks
• Excimer Laser for Hyperopia and Astigmatism
• OTC Eye-Itch Relief
• Stand Magnifier
• Electronic Medical Records System
• Approval for Conjunctivitis Testing


Updated Accommodating IOL

Updated Accommodating IOL Eyeonics has updated its original Crystalens, the first IOL for cataracts to provide accommodation through the use of a hinge mechanism. The redesigned Crystalens Five-O features a larger optic size (from 4.5 to 5 mm) and parallel plates rather than trapezoidal plates.

The Five-O is also designed with 90 percent more plate arc length and 17 percent greater surface area. These features are intended to enhance predictability, facilitate implantation and increase range of plate motion.

Eyeonics
866-393-6642 or 949-389-1790
www.crystalens.com

Flashing Fixation Sticks

Flashing Fixation Sticks Gulden Ophthalmics has released Flashing Fixation Sticks. These two plastic, battery-operated sticks feature fixation flashers to provide a series of detailed accommodation-stimulation targets for the young patient.

Single sticks are intended for performing various tests: unilateral test at near, alternating cover test at near, pursuit testing and near point of convergence, among others. Dual sticks with different targets exposed are designed for saccade testing.

Gulden Ophthalmics
800-659-2250 or 215-884-8105
www.guldenophthalmics.com

Excimer Laser for Hyperopia and Astigmatism

Excimer Laser for Hyperopia and Astigmatism The FDA has approved NIDEK’s EC-5000 excimer laser for the LASIK treatment of hyperopia and hyperopic astigmatism. With this approval, surgeons are able to treat hyperopia and hyperopic astigmatism (+0.5 D to +5 D sphere and up to 2 D cylinder) in addition to the current range for myopia and myopic astigmatism.

NIDEK Inc.
800-223-9044 or 510-226-5700
www.nidek.com

OTC Eye-Itch Relief

The FDA has approved Novartis Ophthalmics’ prescription drug Zaditor (ketotifen fumarate ophthalmic solution 0.025 percent) for over-the-counter use to relieve eye itch caused by common allergens.

Zaditor OTC is offered at full-prescription strength and is intended to provide up to 12 hours of continuous itch relief with one drop. According to Novartis, the drug is the only nonprescription formula to relieve eye itch without a decongestant and the first over-the-counter eye-itch relief drop approved for use in children as young as three.

Zaditor includes an antihistamine and mast cell stabilizer and it is formulated to prevent the release of chemical mediators in order to stop late-phase allergic reaction.

Novartis Ophthalmics
888-669-6682 or 862-778-0788
www.novartisophthalmics.com

Stand Magnifier

Stand Magnifier A new stand magnifier has been released by Eschenbach. Designed to help with low-vision activities, the illuminated Scribolux features a large viewing area and a 100 mm x 75 mm lens that provides 2.8x magnification.

The Scribolux is portable, operates on three AA batteries and uses a surface-mount LED.

Eschenbach
800-487-5389 or 203-438-7471
www.eschenbach.com

Electronic Medical Records System

Electronic Medical Records System GloStream has developed an Electronic Medical Records system (EMR) designed to eliminate paperwork from physicians’ offices.

The GloEMR features built-in voice technology, PDA support, online appointment requests, customizable templates, and automatic scanning with recognition of patient history information.

According to GloStream, this product is in compliance with HIPAA and CMS regulations.

GloStream
877-456-3671 or 248-352-1700
www.gloemr.com

Approval for Conjunctivitis Testing

Rapid Pathogen Screening has received both FDA clearance and a Clinical Laboratory Improvement Amendments (CLIA) waiver for a test called the RPS Adeno Detector.

This 10-minute, in-office test is intended to detect all 51 serotypes of adenoviral conjunctivitis. The RPS Adeno Detector has a sensitivity and specificity that, the company says, approaches viral culture when PCR is used as a reference method.

The test is designed to provide a laboratory-quality confirmation of disease at the point of care.

Rapid Pathogen Screening
800-772-4346 or 570-327-6112
www.rps-tests.com

Disclaimer

Products & Services provides a listing of new products and services for our readers. All information and claims are those of the manufacturers and have not been verified, nor does the appearance of the product constitute an endorsement by the American Academy of Ophthalmology, EyeNet Magazine or the editorial board. We welcome your news of products and services and will feature them on a space-available basis. Please send listings to EyeNet Magazine, Products & Services, 655 Beach St., San Francisco, CA 94109, or e-mail eyenet@aao.org.

About Us Academy Jobs Privacy Policy Contact Us Terms of Service Medical Disclaimer Site Index